CTOs on the Move


 
Inogen`s mission to improve the quality of life of supplemental oxygen users began in 2001 when Mae, a beloved Grandmother, was prescribed oxygen therapy. Learn more about Mae`s Story here: http://www.inogen.com/about-inogen/meet-mae/. Inogen was founded based on our conviction that oxygen therapy technology was not keeping pace with the desired lifestyles of patients who depended on it to live longer, more fulfilling lives. We estimate that more than 2.5 million patients in the United States and more than 4.5 million patients worldwide use oxygen therapy. Our compact, lightweight and travel-approved portable oxygen concentrators are designed to free patients from heavy tanks, ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.inogen.com
  • 326 Bollay Drive
    Goleta, CA USA 93117
  • Phone: 855.631.2438

Executives

Name Title Contact Details

Similar Companies

AMD Global Telemedicine

AMD Global Telemedicine is a Chelmsford, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Conventus Orthopaedics

Taking its name from the Latin word for coming together or union, Conventus Orthopaedics is focused on creating less invasive solutions to fractures in and around joints. The company is dedicated to working with surgeons to improve healing and enable their patients return to normal activity. Specialties

Internal Medical Group

Internal Medical Group is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Advance Medical Designs Inc

Advance Medical Designs Inc is a Marietta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pulse Biosciences

Pulse Biosciences is a novel medical therapy company bringing to market its proprietary CellFX™ Nano-Pulse Stimulation™ (NPS™) platform. The Company`s CellFX NPS platform provides a novel, precise, non-thermal, treatment technology delivering nanosecond duration energy pulses that impact cells in treated tissue while sparing acellular tissue. NPS`s unique mechanism of action disrupts the functions of internal cell structures while maintaining the outer cell membrane initiating a cascade of events within the cell that results in regulated cell death.